Transcription factor therapeutics: long-shot or lodestone

David Ghosh1, Athanasios G Papavassiliou

  • 1Institute for Transcriptional Informatics, PO Box 2556, Pittsburgh, PA 15230, USA. dghosh@ifti.org

Insights

Targeting transcription factors with drugs is complex. This review explores therapeutic strategies, including "transcription therapy," for drug discovery involving transcription factors and signaling molecules.

Area of Science:

  • Molecular Biology
  • Pharmacology
  • Drug Discovery

Background:

  • Transcription factors regulate gene expression and are key targets for drug development.
  • The complex biology of transcriptional regulation poses challenges for designing effective therapies.
  • Many approved and investigational drugs target transcription factors.

Purpose of the Study:

  • To review current therapeutic and drug discovery approaches targeting transcription factors and signaling molecules.
  • To examine the impact of these approaches on transcription factor biology.
  • To highlight the potential of "transcription therapy" as a novel strategy.

Main Methods:

  • Literature review of existing research and drug development pipelines.
  • Analysis of therapeutic strategies targeting transcription factors.
  • Examination of signaling molecules involved in transcriptional regulation.

Main Results:

  • Several approaches are employed to target transcription factors in drug discovery.
  • Understanding transcription factor biology is crucial for effective therapeutic design.
  • "Transcription therapy" represents a promising new avenue for targeting transcription factors.

Conclusions:

  • Developing drugs that target transcription factors requires overcoming biological complexity.
  • Current strategies involve diverse approaches to modulate transcription factor activity.
  • "Transcription therapy" offers a potential breakthrough for future drug development targeting transcription factors.

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...